| International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study F Pagès, B Mlecnik, F Marliot, G Bindea, FS Ou, C Bifulco, A Lugli, ... The Lancet 391 (10135), 2128-2139, 2018 | 1797 | 2018 |
| Towards the introduction of the ‘Immunoscore’in the classification of malignant tumours J Galon, B Mlecnik, G Bindea, HK Angell, A Berger, C Lagorce, A Lugli, ... The Journal of pathology 232 (2), 199-209, 2014 | 1471 | 2014 |
| Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients G Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ... Nature medicine 21 (7), 795, 2015 | 1091 | 2015 |
| Cancer classification using the Immunoscore: a worldwide task force J Galon, F Pagès, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, ... Journal of translational medicine 10 (1), 205, 2012 | 947 | 2012 |
| 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer GL Cascini, A Avallone, P Delrio, C Guida, F Tatangelo, P Marone, L Aloj, ... Journal of Nuclear Medicine 47 (8), 1241-1248, 2006 | 262 | 2006 |
| Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients A Ottaiano, R Franco, AA Talamanca, G Liguori, F Tatangelo, P Delrio, ... Clinical cancer research 12 (9), 2795-2803, 2006 | 250 | 2006 |
| Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections ML Tornesello, L Buonaguro, F Tatangelo, G Botti, F Izzo, FM Buonaguro Genomics 102 (2), 74-83, 2013 | 186 | 2013 |
| Expression of COX‐2, mPGE‐synthase1, MDR‐1 (P‐gp), and Bcl‐xL: a molecular pathway of H pylori‐related gastric carcinogenesis G Nardone, A Rocco, D Vaira, S Staibano, A Budillon, F Tatangelo, ... The Journal of pathology 202 (3), 305-312, 2004 | 142 | 2004 |
| Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial N Normanno, AM Rachiglio, M Lambiase, E Martinelli, F Fenizia, ... Annals of oncology 26 (8), 1710-1714, 2015 | 135 | 2015 |
| Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial F Ciardiello, N Normanno, E Maiello, E Martinelli, T Troiani, S Pisconti, ... Annals of oncology 25 (9), 1756-1761, 2014 | 132 | 2014 |
| Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells A Ottaiano, A di Palma, M Napolitano, C Pisano, S Pignata, F Tatangelo, ... Cancer Immunology, Immunotherapy 54 (8), 781-791, 2005 | 126 | 2005 |
| CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors A Rocco, E Liguori, G Pirozzi, V Tirino, D Compare, R Franco, F Tatangelo, ... Journal of cellular physiology 227 (6), 2686-2693, 2012 | 100 | 2012 |
| BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy M Colombino, P Sperlongano, F Izzo, F Tatangelo, G Botti, A Lombardi, ... Cell death & disease 3 (1), e259, 2013 | 95 | 2013 |
| Limits and potential of targeted sequencing analysis of liquid biopsy in patients with lung and colon carcinoma AM Rachiglio, RE Abate, A Sacco, R Pasquale, F Fenizia, M Lambiase, ... Oncotarget 7 (41), 66595, 2016 | 93 | 2016 |
| Intravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for Hepatocellular carcinoma: correlation with histologic grade V Granata, R Fusco, O Catalano, B Guarino, F Granata, F Tatangelo, ... Oncotarget 7 (48), 79357, 2016 | 89 | 2016 |
| Analysis of APAF‐1 expression in human cutaneous melanoma progression A Baldi, D Santini, P Russo, C Catricalà, A Amantea, M Picardo, ... Experimental dermatology 13 (2), 93-97, 2004 | 86 | 2004 |
| Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX F Ciardiello, N Normanno, E Martinelli, T Troiani, S Pisconti, C Cardone, ... Annals of Oncology 27 (6), 1055-1061, 2016 | 85 | 2016 |
| Hepatic arterial embolization in patients with neuroendocrine tumors M Del Prete, F Fiore, R Modica, V Marotta, F Marciello, V Ramundo, ... Journal of Experimental & Clinical Cancer Research 33 (1), 43, 2014 | 79 | 2014 |
| Extra-mitochondrial localisation of frataxin and its association with IscU1 during enterocyte-like differentiation of the human colon adenocarcinoma cell line Caco-2 F Acquaviva, I De Biase, L Nezi, G Ruggiero, F Tatangelo, C Pisano, ... Journal of cell science 118 (17), 3917-3924, 2005 | 75 | 2005 |
| Upper limb function and quality of life in breast cancer related lymphedema: a cross-sectional study M Pinto, F Gimigliano, F Tatangelo, M Megna, F Izzo, R Gimigliano, ... Eur J Phys Rehabil Med 49 (5), 665-73, 2013 | 69 | 2013 |
